A randomised clinical trial investigating the effect of an anti-epileptic drug.
A data frame with 236 observations on the following 6 variables.
the treatment group, a factor with levels
the number of seizures before the trial.
the age of the patient.
the number of seizures (response variable).
treatment period, an ordered factor with levels
the patient ID, a factor with levels
In this clinical trial, 59 patients suffering from epilepsy were randomized to groups receiving either the anti-epileptic drug Progabide or a placebo in addition to standard chemotherapy. The numbers of seizures suffered in each of four, two-week periods were recorded for each patient along with a baseline seizure count for the 8 weeks prior to being randomized to treatment and age. The main question of interest is whether taking progabide reduced the number of epileptic seizures compared with placebo.
P. F. Thall and S. C. Vail (1990), Some covariance models for longitudinal count data with overdispersion. Biometrics, 46, 657–671.
1 2 3 4 5 6
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.